» Articles » PMID: 15118484

Clinical Rating Scales and Instruments: How Do They Compare in Assessing Abnormal, Involuntary Movements?

Overview
Specialty Pharmacology
Date 2004 May 1
PMID 15118484
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: Recent studies have shown that quantitative instrumental measurements are more sensitive than clinical rating scales to subclinical dyskinesia and parkinsonism. We therefore hypothesized that an instrumental assessment would be more sensitive to the presence of dyskinetic and parkinsonian movements than the Abnormal Involuntary Movement Scale (AIMS), the Dyskinesia Identification Scale, Condensed User Version (DISCUS), and the Simpson-Angus Scale (SAS). We also hypothesized that the DISCUS, by virtue of its more detailed protocol, would be more sensitive than the AIMS.

Method: Using blinded raters, we compared the clinical rating scales with instrumental measurements in 100 patients referred to a movement disorders clinic. We collected demographic data, risk factors for tardive dyskinesia, current medication use, Axis I and III disorders, and an estimate of cognitive functioning using the Mini-Mental Status Examination.

Results: There was no significant difference between the AIM and the DISCUS in the identification of dyskinesia. However, an instrumental assessment revealed a significantly greater prevalence of dyskinesia. The Mini-Mental Status Examination was the most prominent predictor of both instrumental and clinical measurements of parkinsonian and dyskinetic movements.

Conclusions: It appears that even trained raters, utilizing standard rating scales, may underestimate the prevalence of some motor abnormalities. Instrumental ratings may be helpful to both the clinician and investigator, particularly when abnormal movements are not clinically obvious. The relationship between cognitive impairment and motor abnormalities remains an important area for further research.

Citing Articles

An Instrumental Measure of Hand and Facial Movement Abnormalities in Patients With Schizophrenia.

Wang S, Ouyang W, Hsu H, Hsu L Front Psychiatry. 2022; 13:803661.

PMID: 35308887 PMC: 8931260. DOI: 10.3389/fpsyt.2022.803661.


Assessment of the Impact of Tardive Dyskinesia in Clinical Practice: Consensus Panel Recommendations.

Jackson R, Brams M, Citrome L, Hoberg A, Isaacson S, Kane J Neuropsychiatr Dis Treat. 2021; 17:1589-1597.

PMID: 34079257 PMC: 8164384. DOI: 10.2147/NDT.S310605.


Exploring Movement Impairments in Patients With Parkinson's Disease Using the Microsoft Kinect Sensor: A Feasibility Study.

Ruda D, Einarsson G, Schott Andersen A, Matthiassen J, Correll C, Winge K Front Neurol. 2021; 11:610614.

PMID: 33488503 PMC: 7815696. DOI: 10.3389/fneur.2020.610614.


Motor Disturbance in ASD: A Pilot Study Showing Hypokinetic Behavior?.

Mostert-Kerckhoffs M, Willems A, Tenback D, Koning J, Van Harten P, Staal W J Autism Dev Disord. 2019; 50(2):415-428.

PMID: 31673907 DOI: 10.1007/s10803-019-04171-1.


Instrument-based assessment of motor function yields no evidence of dyskinesia in adult first-degree biological relatives of individuals with schizophrenia and schizoaffective disorder.

Kent J, Caligiuri M, Skorheim M, Lano T, Mittal V, Sponheim S Psychiatry Res. 2018; 272:135-140.

PMID: 30580137 PMC: 6397690. DOI: 10.1016/j.psychres.2018.12.007.